At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
Glutamine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy.
In Brief
A clinical study evaluating Glutamine, Ringer's Lactate, and 1 other intervention for Hemorrhagic Shock. Completed, enrolled 5 participants across 2 sites.
Detailed Summary
Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhagic Shock
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2010
Enrollment StartJan 2011
Primary CompletionNov 2013
Study CompletionDec 2013
TodayJul 2026
First PostedNov 11, 2010
Enrollment StartJan 1, 2011
Primary CompletionNov 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 15.6 years ago
Interventions
Glutaminedrug
Intravenous 25 grams once over 6 hours
Ringer's Lactatedrug
Intravenous 1 liter once over 6 hours
Placebo (for Glutamine)drug
Given Intravenously in 1 liter Lactated Ringer's